Kensington Investment Counsel’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.61M | Buy |
35,615
+1,231
| +4% | +$228K | 2.84% | 7 |
|
|
2025
Q1 | $7.2M | Buy |
34,384
+2,192
| +7% | +$459K | 3.2% | 4 |
|
|
2024
Q4 | $5.72M | Buy |
32,192
+1,320
| +4% | +$235K | 2.39% | 9 |
|
|
2024
Q3 | $6.1M | Buy |
30,872
+316
| +1% | +$62.4K | 2.55% | 6 |
|
|
2024
Q2 | $5.24M | Buy |
30,556
+1,280
| +4% | +$220K | 2.32% | 8 |
|
|
2024
Q1 | $5.33M | Buy |
29,276
+1,696
| +6% | +$309K | 2.43% | 8 |
|
|
2023
Q4 | $4.27M | Buy |
27,580
+2,742
| +11% | +$425K | 2.24% | 9 |
|
|
2023
Q3 | $3.7M | Buy |
24,838
+783
| +3% | +$117K | 2.3% | 6 |
|
|
2023
Q2 | $3.24M | Buy |
24,055
+2,709
| +13% | +$365K | 2.05% | 7 |
|
|
2023
Q1 | $3.4M | Sell |
21,346
-2,788
| -12% | -$444K | 2.57% | 5 |
|
|
2022
Q4 | $3.9M | Buy |
24,134
+331
| +1% | +$53.5K | 3.06% | 3 |
|
|
2022
Q3 | $3.2M | Buy |
23,803
+1,193
| +5% | +$160K | 2.69% | 3 |
|
|
2022
Q2 | $3.46M | Sell |
22,610
-400
| -2% | -$61.3K | 2.95% | 3 |
|
|
2022
Q1 | $3.73M | Buy |
23,010
+1,149
| +5% | +$186K | 2.47% | 3 |
|
|
2021
Q4 | $2.96M | Buy |
+21,861
| New | +$2.96M | 1.73% | 13 |
|
|
2021
Q2 | $2.43M | Buy |
21,566
+867
| +4% | +$97.7K | 1.67% | 15 |
|
|
2021
Q1 | $2.24M | Buy |
20,699
+2,513
| +14% | +$272K | 1.68% | 15 |
|
|
2020
Q4 | $1.95M | Buy |
+18,186
| New | +$1.95M | 1.61% | 14 |
|